Suppr超能文献

年龄对初次经皮冠状动脉介入治疗(裸金属支架或药物洗脱支架)后长期预后的影响(来自 DESERT 合作研究)。

Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation).

机构信息

Division of Cardiology, Ospedale Maggiore della Carità, Eastern Piedmont University, Novara, Italy.

出版信息

Am J Cardiol. 2013 Jul 15;112(2):181-6. doi: 10.1016/j.amjcard.2013.03.012. Epub 2013 May 7.

Abstract

Despite mechanical reperfusion, elderly patients with ST-segment elevation myocardial infarction (STEMI) still experience unsatisfactory outcomes. Drug-eluting stents (DES) have significantly reduced target-vessel revascularization (TVR), but concerns have emerged about the higher risk of late stent thrombosis, which may be more pronounced in elderly patients. Therefore, the aim of this study was to evaluate the impact of age on outcome in patients with STEMI who underwent primary angioplasty with bare-metal stents (BMS) or DES. Our population comprised 6,298 patients who underwent primary angioplasty and stent implantation included in the Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation database. Age was significantly associated with female gender (p <0.001), diabetes (p <0.001), hypertension (p <0.001), previous myocardial infarction (MI; p <0.001), ischemia time (p <0.001), and anterior MI (p <0.001) but inversely related to smoking (p <0.001). Elderly patients most often had infarct-related artery located in the descending artery (p = 0.014) and impaired postprocedural thrombolysis in myocardial infarction flow (p <0.001). Elderly patients were less often on clopidogrel at follow-up. At long-term follow-up, age was associated with a higher rate of death (hazard ratio [95% confidence interval] = 2.17 [1.97 to 2.39], p <0.0001), whereas no impact was observed on reinfarction (p = 0.36), stent thrombosis (p = 0.84), and TVR (p = 0.54). These results were confirmed in patients receiving both BMS and DES. The impact of age on mortality was confirmed after correction for baseline confounding factors (gender, diabetes hypertension, hypercholesterolemia, smoking, ischemia time, anterior MI, infarct-related artery location, and postprocedural thrombolysis in myocardial infarction 3 flow; adjusted hazard ratio [95% confidence interval] = 2.13 [1.78 to 2.56], p <0.001). In conclusion, this study shows that in patients with STEMI who underwent primary angioplasty, age is independently associated with higher mortality, observed with both BMS and DES, whereas no impact was observed on the rate of reinfarction, stent thrombosis, and TVR.

摘要

尽管进行了机械再灌注,ST 段抬高型心肌梗死(STEMI)的老年患者仍存在不理想的结局。药物洗脱支架(DES)显著降低了靶血管血运重建(TVR),但人们对晚期支架内血栓形成的风险增加表示担忧,而这种风险在老年患者中可能更为明显。因此,本研究旨在评估年龄对接受经皮冠状动脉介入治疗(PCI)置入裸金属支架(BMS)或 DES 的 STEMI 患者结局的影响。我们的研究人群包括 6298 例在药物洗脱支架用于直接经皮冠状动脉介入治疗(DESERT)合作数据库中接受直接 PCI 及支架植入的患者。年龄与女性(p<0.001)、糖尿病(p<0.001)、高血压(p<0.001)、既往心肌梗死(MI;p<0.001)、缺血时间(p<0.001)和前壁 MI(p<0.001)显著相关,而与吸烟(p<0.001)呈负相关。老年患者梗死相关动脉更常位于降支(p=0.014),且术后心肌梗死溶栓试验(TIMI)血流分级较差(p<0.001)。老年患者在随访时更常停用氯吡格雷。长期随访发现,年龄与死亡率升高相关(风险比[95%置信区间]为 2.17[1.97 至 2.39],p<0.0001),但再梗死(p=0.36)、支架内血栓形成(p=0.84)和 TVR(p=0.54)无影响。这一结果在接受 BMS 和 DES 治疗的患者中得到了证实。在校正了基线混杂因素(性别、糖尿病、高血压、高胆固醇血症、吸烟、缺血时间、前壁 MI、梗死相关动脉位置和术后 TIMI 血流 3 级)后,年龄对死亡率的影响仍然存在(校正风险比[95%置信区间]为 2.13[1.78 至 2.56],p<0.001)。总之,本研究表明,在接受直接 PCI 的 STEMI 患者中,年龄与死亡率升高独立相关,且与 BMS 和 DES 治疗相关,而再梗死、支架内血栓形成和 TVR 发生率无影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验